Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004403 |
---|---|
Receipt number | R000005263 |
Scientific Title | A phase I/II study of Cetuximab combined with irinotecan and S-1 as first line therapy in metastatic colorectal cancer patients with KRAS wild type |
Date of disclosure of the study information | 2010/11/01 |
Last modified on | 2016/04/18 09:58:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/10/18 20:00:29 | ||
2 | Update | 2016/04/18 09:58:31 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |